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Evidence from a quasi-experimental study for the effectiveness of the influenza vaccination 
against myocardial infarction in UK adults aged at least 65y 
 
Background 
 
A recent investigation using routinely collected health records found the influenza vaccine 
to be effective against heart failure. However, treatment of overt myocardial infarction (MI) 
events is important in preventing progression to heart failure, especially in older adults, yet 
evidence for the association between respiratory disease and subsequent MI is from 
observational data and subject to confounding bias. 
 
 
Objectives 
 
Using linked electronic health records, this study aimed to adjust for unmeasured 
confounding in the estimation of the effectiveness of the influenza vaccine against MI in 
adults aged 65y and older in the UK. 
 
Method 
 
Design 
 
Cohorts of patients in the UK from general practices registered to the Clinical Practice 
Research Datalink with linkage to Hospital Episode Statistics. 
 
Setting 
 
Adults aged 65y and older recruited from September in annual cohorts from 1997 to 2012 
with no record of influenza vaccination in the preceding five years.  
 
Exposure 
 
Influenza vaccination 
  
Outcome measure 
 
Hospitalisation for MI as set out in the protocol for the study. 
 
Statistical analysis 
 
Survival times until MI in new beneficiaries of the influenza vaccine versus patients without 
vaccination were analysed for each annual cohort using a novel pairwise method to adjust 
for confounding bias. This alternative formulation of the prior event rate ratio method 
utilised data on each annual cohort from the preceding vaccine-free year, and the results 
from both methods were compared. 
 
 
Results 
 
Cohort sizes ranged from 56151 patients in 2002 to 144566 in 2012. The hazard ratios (HR) 
for influenza vaccination from a Cox regression adjusting for age and gender were either 
greater than, or not significantly different from unity. After adjustment using the PERR 
method, the HRs were significantly less than unity (at 5% level), varying between 0.43 and 
0.74, except in 2001 (HR=0.89). The same annual trend was closely mirrored in the pairwise-
adjusted results, which were significantly below unity, varying between 0.37 and 0.66, 
except for 2001 (HR=0.81). 
 
Conclusions 
 
After adjustment for unmeasured confounding bias, there was real-world evidence of a 
protective effect against MI from the influenza vaccination in patients aged 65y and older in 
every from year 1997 to 2012, except 2001. 
 
